| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
| 04/25/2001 | EP1093818A1 Powdery preparation for mucosal administration containing polymeric medicine |
| 04/25/2001 | EP1093814A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 04/25/2001 | EP1093521A2 Human transferases |
| 04/25/2001 | EP1093516A2 Mammalian genes; dendritic cell prostaglandin-like transporter (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093453A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 04/25/2001 | EP1093380A2 Component b as angiogenic agent in combination with human growth factors |
| 04/25/2001 | EP1093377A1 Inclusion of apoptotic regulators in solutions for cell storage at low temperature |
| 04/25/2001 | EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 04/25/2001 | EP1093369A2 Agents with an antidepressive effect |
| 04/25/2001 | EP1093367A1 Protease inhibitors |
| 04/25/2001 | EP1093365A2 Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain |
| 04/25/2001 | EP1093363A1 Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection |
| 04/25/2001 | EP1093362A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators |
| 04/25/2001 | EP1093361A1 Plaster which contains steroids, and a method for the production and use thereof |
| 04/25/2001 | EP1093348A1 Methods and transdermal compositions for pain relief |
| 04/25/2001 | EP1007068A4 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1292795A Certain dinucleotides and their use as membrana mucosa cilium clearing and cilium vibration frequency regulating agent |
| 04/25/2001 | CN1292789A 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| 04/25/2001 | CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/25/2001 | CN1292783A Method for preparing sulfanyl-type endothelin receptor antagonists |
| 04/25/2001 | CN1292782A Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed ETA/ETB-receptor antagonists |
| 04/25/2001 | CN1292779A Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 04/25/2001 | CN1292701A Glucocorticoid receptor antagonists for treatment of dementia |
| 04/25/2001 | CN1292698A Glycine transport inhibitors |
| 04/25/2001 | CN1292696A Composition |
| 04/25/2001 | CN1292695A Use of macrolide compounds for treatment of ARDS |
| 04/25/2001 | CN1292693A Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 04/25/2001 | CN1292690A Use of alpha-RAR antagonists for inhibition of mucin secretion |
| 04/25/2001 | CN1292677A Mixture for oxidation tinting of keratin fibres containing laccase and tinting method using said mixture |
| 04/25/2001 | CN1292293A Infantile hernia truss and its making method |
| 04/25/2001 | CN1292264A Phosphodiesterase inhibitor and its use |
| 04/25/2001 | CN1064966C Condesned thiazole derivatives, having 5-HT receptor affinity |
| 04/25/2001 | CN1064959C N-substituted azabicycloheptane derivatives and preparing process and use thereof |
| 04/25/2001 | CN1064955C Fluorine-containing benzoylguanidines |
| 04/25/2001 | CN1064954C Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same |
| 04/25/2001 | CN1064952C New substituted 2,2-dimethyl-omega-phenoxyalkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
| 04/24/2001 | US6222062 Beta-ketoester compounds |
| 04/24/2001 | US6222038 As substance p antagonists; in therapy of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6222034 As serotinin receptor antagonists; for therapy of depression, central nervous system disorders |
| 04/24/2001 | US6221958 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/24/2001 | US6221904 Administering to the subject an amount of dehydroascorbic acid |
| 04/24/2001 | US6221892 Heterocyclic topoisomerase poisons |
| 04/24/2001 | US6221889 Interleukin antagonist; skin disorders, respiratory system disorders, rheumatic disorders |
| 04/24/2001 | US6221887 Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/24/2001 | US6221879 8-azabicyclo[3.2.1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors |
| 04/24/2001 | US6221876 190 kda multidrug resistance protein (mrp1); 1-amino-2-hydroxyindan-6-yl)isoxazolo(3, 4-c)-1,2-dihydro-3-methyl-6-chloroquinolin-2-one derivatives |
| 04/24/2001 | US6221873 Cyclin dependent kinase inhibitor |
| 04/24/2001 | US6221870 Treatment of depression, anxiety, bipolar disorders and adhd |
| 04/24/2001 | US6221867 4,5-pyrazinoxindoles |
| 04/24/2001 | US6221852 Pharmaceutical compositions of 5-alkynyl-dideoxyribouracil |
| 04/24/2001 | US6221849 Inhibiting tumor growth |
| 04/24/2001 | US6221848 In vivo administration to the subject of a polynucleotide encoding a protein that is transiently expressed in said subject; preventing esophagitis during treatment of lung cancer patients with ionizing radiation and/or chemotherapy |
| 04/24/2001 | US6221670 Methods to identify β-amyloid reducing agents |
| 04/24/2001 | US6221667 Packaged pharmaceutical composition includes a mobile ionophore which prevents or decreases amyloid precursor protein catabolism in cells without altering cell viability in a pharmaceutical vehicle in a container, and instructions |
| 04/24/2001 | US6221649 Chimeric bacillus thuringiensis-endotoxins and host cells expressing same |
| 04/24/2001 | US6221627 cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
| 04/24/2001 | US6221616 Detecting modulators of receptor binding protein; incubate cells with modulators and monitoring reduction in binding activity at receptor |
| 04/24/2001 | US6221613 Utilizing competitive binding to detect preferential modulator activity on receptor binding protein; incubate cells with modulators and monitor binding, detect amplification or reduction of binding to receptors |
| 04/24/2001 | CA2222976C Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 04/24/2001 | CA2220055C Dipeptides which promote release of growth hormone |
| 04/24/2001 | CA2165192C Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 04/24/2001 | CA2101164C Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 04/24/2001 | CA2085885C Alteration of rate and character of hair growth |
| 04/24/2001 | CA2073166C Process to correct and optimize the composition of a feed |
| 04/24/2001 | CA2053277C Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 04/24/2001 | CA1341216C Human .alpha.-1-antitrypsin derivatives, and a production process |
| 04/19/2001 | WO2001027635A1 Multiwell scanner and scanning method |
| 04/19/2001 | WO2001027622A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | WO2001027314A1 Antiprotozoal histone acetyl transferase inhibitors |
| 04/19/2001 | WO2001027305A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | WO2001027280A1 Antimicrobial compositions |
| 04/19/2001 | WO2001027273A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | WO2001027271A1 Novel c-type lectin and gene thereof |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027265A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/19/2001 | WO2001027261A2 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | WO2001027255A2 Nucleic acid coding for a ctage gene family, use and production thereof |
| 04/19/2001 | WO2001027157A1 A biologically active complex of nr6 and cardiotrophin-like-cytokine |
| 04/19/2001 | WO2001027152A1 Method of altering polypeptide aggregation |
| 04/19/2001 | WO2001027146A2 Chemokine receptor |
| 04/19/2001 | WO2001027140A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | WO2001027136A2 Peptides which stimulate the immune response and tissue regeneration |
| 04/19/2001 | WO2001027135A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/19/2001 | WO2001027132A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | WO2001027131A1 Purine derivatives |
| 04/19/2001 | WO2001027128A1 C-aryl glucoside sglt2 inhibitors |
| 04/19/2001 | WO2001027119A2 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines |
| 04/19/2001 | WO2001027114A1 PYRROLO[2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
| 04/19/2001 | WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 04/19/2001 | WO2001027110A2 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring |
| 04/19/2001 | WO2001027109A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027105A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 04/19/2001 | WO2001027103A1 Fab i inhibitors |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |